Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery
Go back to Schrödinger to Participate in BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery| Standard Gold Holdings, Inc. (NASDAQ: SDGR) | Delayed: 18.85 +0.05 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.80 | 52 Week High | $0.74 | |||
| Open | $18.93 | 52 Week Low | $0.11 | |||
| Day High | $19.00 | P/E | N/A | |||
| Day Low | $18.74 | EPS | $-0.07 | |||
| Volume | 52,885 | |||||
